2 Exceptional Dividend Stocks Near 52-Week Lows You Could Regret Not Buying on the Dips

Group 1: W.P. Carey - W.P. Carey is a real estate investment trust (REIT) trading approximately 35% below its 2022 peak, currently offering a 6.2% yield [3][5] - The REIT has a 98.8% occupancy rate after spinning off 59 buildings into another company, which has allowed it to focus on its remaining properties [3][6] - W.P. Carey has raised its dividend payout three times since the spinoff and expects adjusted funds from operations to be between $4.65 and $4.71 per share this year, significantly above its current dividend obligation of $3.50 annually [5][6] - The REIT owns 1,430 single-tenant buildings across Europe and North America, with a well-diversified tenant list [6][7] Group 2: Royalty Pharma - Royalty Pharma offers a 3.2% yield and invests in drugmakers in exchange for royalty stakes in their products, benefiting from the reliable trend of increasing prescription drug expenses [8][9] - The company has a stake in 15 blockbuster drugs generating over $1 billion in annual sales and has raised its dividend four times since going public in 2020, totaling a 40% increase [9][10] - Royalty Pharma has announced transactions worth $10.1 billion since the start of 2022, with expectations for significant earnings growth in the coming years [10][11] - The company is positioned to capitalize on the need for over $1 trillion in capital for startup drugmakers over the next decade, making it a leading provider of royalty financing [11]